Pharma

Your Article Summary

See Latest Articles

AVI BioPharma Strengthens Patent Position in Exon Skipping
AVI BioPharma, 11/25/08

AVI BioPharma, Inc., a developer of RNA–based drugs, announced the signing of an exclusive worldwide license agreement with the University of Western Australia (UWA) to a patent application related to the treatment of Duchenne Muscular Dystrophy (DMD).

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi Pasteur and the Alliance for Rabies Control enter into a global partnership
Sanofi-aventis, 10/05/09

Sanofi-aventis to acquire Oenobiol, French leader in nutritional beauty supplements
Sanofi-aventis, 11/02/09

GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
GlaxoSmithKline, 10/14/09

See All of M&A/Partnerships